Frontier Capital Management CO LLC Exact Sciences Corp Transaction History

Frontier Capital Management CO LLC

$9.58 Billion
Q2 2024

A detailed history of Frontier Capital Management CO LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 705,468 shares of EXAS stock, worth $47.9 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

705,468

Previous 656,056 7.53%

Holding current value

$47.9 Million

Previous $45.3 Million 34.21%

% of portfolio

0.31%

Previous 0.44%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $2.04 Million - $3.67 Million	49,412 Added 7.53%	705,468 $29.8 Million
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $4.15 Million - $5.45 Million	73,835 Added 12.68%	656,056 $45.3 Million
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $6.68 Million - $8.57 Million	113,154 Added 24.12%	582,221 $43.1 Million
Q3 2023 Nov 14, 2023	SELL	$65.94 - $99.04 $4.03 Million - $6.05 Million	-61,067 Reduced 11.52%	469,067 $32 Million
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $13.7 Million - $20.7 Million	-217,832 Reduced 29.12%	530,134 $49.8 Million
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $5.39 Million - $8.08 Million	-114,129 Reduced 13.24%	747,966 $50.7 Million
Q4 2022 Feb 14, 2023	BUY	$30.35 - $53.15 $8.85 Million - $15.5 Million	291,616 Added 51.12%	862,095 $42.7 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $1.33 Million - $2.06 Million	41,719 Added 7.89%	570,479 $18.5 Million
Q2 2022 Jul 20, 2022	SELL	$35.61 - $76.23 $42,625 - $91,247	-1,197 Reduced 0.23%	528,760 $20.8 Million
Q1 2022 Apr 14, 2022	SELL	$57.56 - $82.54 $3.89 Million - $5.57 Million	-67,508 Reduced 11.3%	529,957 $37.1 Million
Q4 2021 Jan 19, 2022	SELL	$72.5 - $100.68 $2.15 Million - $2.98 Million	-29,595 Reduced 4.72%	597,465 $46.5 Million
Q3 2021 Oct 19, 2021	SELL	$90.24 - $124.05 $11.3 Million - $15.5 Million	-125,260 Reduced 16.65%	627,060 $59.9 Million
Q2 2021 Aug 09, 2021	SELL	$93.66 - $139.27 $394,870 - $587,162	-4,216 Reduced 0.56%	752,320 $93.5 Million
Q1 2021 May 13, 2021	SELL	$116.57 - $155.01 $46.3 Million - $61.6 Million	-397,097 Reduced 34.42%	756,536 $99.7 Million
Q4 2020 Jan 19, 2021	SELL	$99.61 - $142.12 $27 Million - $38.5 Million	-271,000 Reduced 19.02%	1,153,633 $153 Million
Q3 2020 Nov 16, 2020	SELL	$72.92 - $102.01 $16.3 Million - $22.7 Million	-222,919 Reduced 13.53%	1,424,633 $145 Million
Q2 2020 Jul 17, 2020	BUY	$55.75 - $92.75 $23.5 Million - $39.1 Million	421,764 Added 34.41%	1,647,552 $143 Million
Q1 2020 Apr 16, 2020	BUY	$37.9 - $104.44 $7.31 Million - $20.1 Million	192,865 Added 18.67%	1,225,788 $71.1 Million
Q4 2019 Feb 14, 2020	BUY	$77.66 - $99.74 $14.2 Million - $18.3 Million	183,103 Added 21.55%	1,032,923 $95.5 Million
Q3 2019 Nov 14, 2019	SELL	$90.37 - $122.49 $1.68 Million - $2.28 Million	-18,636 Reduced 2.15%	849,820 $76.8 Million
Q2 2019 Aug 14, 2019	SELL	$89.51 - $118.04 $10.7 Million - $14.1 Million	-119,182 Reduced 12.07%	868,456 $103 Million
Q1 2019 May 07, 2019	SELL	$61.98 - $96.5 $15.3 Million - $23.9 Million	-247,208 Reduced 20.02%	987,638 $85.5 Million
Q4 2018 Jan 25, 2019	SELL	$56.04 - $82.66 $19.7 Million - $29 Million	-351,005 Reduced 22.13%	1,234,846 $77.9 Million
Q3 2018 Oct 30, 2018	BUY	$48.29 - $80.6 $21 Million - $35 Million	434,184 Added 37.7%	1,585,851 $125 Million
Q2 2018 Aug 03, 2018	BUY	$37.84 - $69.96 $1.15 Million - $2.13 Million	30,376 Added 2.71%	1,151,667 $68.9 Million
Q1 2018 Apr 30, 2018	BUY	$39.82 - $57.53 $9.13 Million - $13.2 Million	229,212 Added 25.69%	1,121,291 $45.2 Million
Q4 2017 Jan 18, 2018	SELL	$46.49 - $60.51 $1.15 Million - $1.49 Million	-24,634 Reduced 2.69%	892,079 $46.9 Million
Q3 2017 Oct 31, 2017	BUY	$37.05 - $47.12 $34 Million - $43.2 Million	916,713	916,713 $43.2 Million

Others Institutions Holding EXAS

# of Institutions

610

Shares Held

166M

Call Options Held

1.93M

Put Options Held

1.23M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $12B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account

Frontier Capital Management CO LLC Exact Sciences Corp Transaction History